Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.
Rookie Yesavage to face veteran Snell in World Series opener as Blue Jays seek first title since 1993
Proxy adviser ISS recommends rejecting CoreWeave's $9 billion bid to acquire Core Scientific, citing concerns over the "rushed sale process" and "fixed exchange ratio" that undervalue Core Scientific.
Rookie Yesavage to face veteran Snell in World Series opener as Blue Jays seek first title since 1993